GTC
ACOR

Ghost Tree Capital’s Acorda Therapeutics ACOR Stock Holding History

Ghost Tree Capital’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-275
Closed -$947K – 62
2018
Q2 		$947K Buy
+275
New +$842K 0.28% 38
2017
Q3 		– Sell
-3,333
Closed -$7.88M – 79
2017
Q2 		$7.88M Buy
3,333
+833
+33% +$1.65M 1.64% 20
2017
Q1 		$6.3M Buy
2,500
+2,333
+1,397% +$6.72M 1.17% 37
2016
Q4 		$376K Sell
167
-1,916
-92% -$4.56M 0.09% 68
2016
Q3 		$5.22M Sell
2,083
-625
-23% -$1.86M 0.85% 44
2016
Q2 		$8.29M Buy
+2,708
New +$8.81M 2.39% 12
2016
Q1 		– Sell
-833
Closed -$4.28M – 68
2015
Q4 		$4.28M Hold
833
– – 1.75% 23
2015
Q3 		$2.65M Buy
+833
New +$3.23M 1.19% 36

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ghost Tree Capital's ACOR Position: Q3 2018 in Review

Ghost Tree Capital sold out of Acorda Therapeutics (ACOR) in Q3 2018, closing a stake of 275 shares — an estimated $947K sold.

Ghost Tree Capital first reported a position in ACOR in Q3 2015 and held it in 8 quarters. The position peaked at $8.29M in Q2 2016. 174 funds tracked by Wall St. Rank hold ACOR as of Q3 2018.

  • Ghost Tree Capital reported no remaining Acorda Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Ghost Tree Capital sold 275 Acorda Therapeutics shares in Q3 2018, an estimated $947K.
  • Ghost Tree Capital first reported a position in Acorda Therapeutics in Q3 2015 and held it in 8 quarters.
  • Ghost Tree Capital's Acorda Therapeutics position peaked at $8.29M in Q2 2016.
  • 174 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2018.

Based on Ghost Tree Capital's 13F filing for Q3 2018, filed 14 Nov 2018.